| DFFVX | LRSRX | DFFVX / LRSRX | |
| Total Expense Ratio | 0.29 | 1.46 | 20% |
| Annual Report Gross Expense Ratio | 0.30 | 1.46 | 21% |
| Fund Existence | 26 years | 18 years | - |
| Gain YTD | 8.680 | 6.599 | 132% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 14.9B | 384M | 3,880% |
| Annual Yield % from dividends | 1.58 | 0.14 | 1,118% |
| Returns for 1 year | 17.44 | -0.14 | -12,262% |
| Returns for 3 years | 37.63 | 7.26 | 518% |
| Returns for 5 years | 62.65 | -7.96 | -787% |
| Returns for 10 years | 141.58 | -24.37 | -581% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| MCYCX | 14.37 | 0.48 | +3.46% |
| NYLI Candriam Emerging Markets Eq Cl C | |||
| EQIRX | 16.35 | 0.22 | +1.36% |
| Allspring Emerging Markets Eq Advtg R6 | |||
| FVDKX | 40.52 | N/A | N/A |
| Fidelity Value Discovery K | |||
| GSURX | 62.38 | -0.70 | -1.11% |
| Goldman Sachs US Equity Insights R | |||
| VPMAX | 194.37 | -2.54 | -1.29% |
| Vanguard PRIMECAP Adm | |||